Development and validation of a machine-learning model for predicting prognosis in critically ill patients undergoing major surgery
Source check: Source checked. Not independent scientific confirmation.
Finding: XGBoost models predict 28-day and hospital mortality in critically ill major-surgery patients; a compact 10-feature model was externally validated.
Technology: XGBoost models use early ICU data to predict 28-day and hospital mortality in critically ill patients after major surgery.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- XGBoost models use early ICU data to predict 28-day and hospital mortality in critically ill patients after major surgery.
- Test and result
- XGBoost models predict 28-day and hospital mortality in critically ill major-surgery patients; a compact 10-feature model was externally validated. Full Methods/Results in NCBI PMC BioC; MIMIC-IV development and university-hospital external validation reviewed.
- Limitation / still unknown
- The study does not establish performance or consequences beyond the reported cohort, datasets, task or experimental setup.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12574182/ · https://pmc.ncbi.nlm.nih.gov:443/articles/PMC12574182/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.